TY  - JOUR 
AU  - Teo, Katy
AU  - Gómez Cuadrado, Laura
AU  - Tenhagen, Milou
AU  - Byron, Adam
AU  - Ratze, Max
AU  - Amersfoort, Miranda van
AU  - Renes, Jojanneke
AU  - Strengman, Eric
AU  - Mandoli, Amit
AU  - Singh, Abhishek
AU  - Martens, Joost H.A.
AU  - Stunnenberg, Hendrik G.
AU  - Diest, Paul J. van
AU  - Brunton, Valerie G.
AU  - Derksen, Patrick W.B.
PY  - 2018
UR  - http://hdl.handle.net/10259/9797
AB  - Despite the fact that loss of E-cadherin is causal to the development and progression of invasive lobular carcinoma (ILC), options to treat this major breast cancer subtype are limited if tumours develop resistance to anti- oestrogen treatment...
LA  - eng
PB  - Nature Research
KW  - E-cadherin
KW  - Invasive lobular carcinoma
KW  - Breast cancer treatment
KW  - P13-kinase
KW  - AKT
KW  - Targeted treatment
KW  - Reverse-phase protein array
KW  - Oncología
KW  - Oncology
KW  - Química orgánica
KW  - Chemistry, Organic
KW  - Salud
KW  - Health
TI  - E-cadherin loss induces targetable autocrine activation of growth factor signalling in lobular breast cancer
DO  - 10.1038/s41598-018-33525-5
T2  - Scientific Reports
VL  - 8
ER  -